These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 15346250)

  • 21. [Treatment of hepatitis C virus infection].
    Zeuzem S
    Praxis (Bern 1994); 2005 May; 94(18):721-6. PubMed ID: 15938383
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of hepatitis C in HIV infected and other immunocompromised individuals.
    Seth AK
    Trop Gastroenterol; 2006; 27(3):111-7. PubMed ID: 17310553
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of posttransplantation recurrence of hepatitis C with interferon and ribavirin: lessons on tolerability and efficacy.
    Narayanan Menon KV; Poterucha JJ; El-Amin OM; Burgart LJ; Kremers WK; Rosen CB; Wiesner RH; Charlton M
    Liver Transpl; 2002 Jul; 8(7):623-9. PubMed ID: 12089717
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of recurrent hepatitis C after liver transplantation: a concise review.
    Szabo G; Katz E; Bonkovsky HL
    Am J Gastroenterol; 2000 Sep; 95(9):2164-70. PubMed ID: 11007212
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictors of alpha-fetoprotein elevation in patients with chronic hepatitis C, but not hepatocellular carcinoma, and its normalization after pegylated interferon alfa 2a-ribavirin combination therapy.
    Chen TM; Huang PT; Tsai MH; Lin LF; Liu CC; Ho KS; Siauw CP; Chao PL; Tung JN
    J Gastroenterol Hepatol; 2007 May; 22(5):669-75. PubMed ID: 17444854
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of chronic hepatitis C in human immunodeficiency virus/hepatitis C virus-coinfected patients in the era of pegylated interferon and ribavirin.
    Bräu N
    Semin Liver Dis; 2005 Feb; 25(1):33-51. PubMed ID: 15731996
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of patients with recurrent hepatitis C after liver transplantation with peginterferon alfa-2B plus ribavirin.
    Neumann U; Puhl G; Bahra M; Berg T; Langrehr JM; Neuhaus R; Neuhaus P
    Transplantation; 2006 Jul; 82(1):43-7. PubMed ID: 16861940
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of ribavirin in patients with chronic HCV genotype 1: when enough is really enough.
    Shiffman ML; Rustgi VK
    Gastroenterology; 2006 Oct; 131(4):1339-41. PubMed ID: 17030201
    [No Abstract]   [Full Text] [Related]  

  • 29. Chronic hepatitis C responds poorly to combination therapy in chronic hepatis B carriers.
    Senturk H; Tahan V; Canbakan B; Uraz S; Ulger Y; Ozaras R; Tabak F; Mert A; Ozbay G
    Neth J Med; 2008 May; 66(5):191-5. PubMed ID: 18490796
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transplantation for chronic hepatitis B and C: strategies for prevention and treatment of recurrent disease.
    Reddy KR
    Indian J Gastroenterol; 2001 Mar; 20 Suppl 1():C59-63. PubMed ID: 11293183
    [No Abstract]   [Full Text] [Related]  

  • 31. Hepatic transplant and HCV: a new playground for an old virus.
    Chinnadurai R; Velazquez V; Grakoui A
    Am J Transplant; 2012 Feb; 12(2):298-305. PubMed ID: 22044693
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The natural history of chronic hepatitis C virus infection.
    Seeff LB
    Clin Liver Dis; 1997 Nov; 1(3):587-602. PubMed ID: 15560060
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HCV infection should be managed in specialist centres.
    Dusheiko G
    Gut; 2002 Nov; 51(5):625-6. PubMed ID: 12377796
    [No Abstract]   [Full Text] [Related]  

  • 34. Commentary on: Treatment of HCV infection in chronic kidney disease.
    Alavian SM
    Nefrologia; 2011; 31(5):607; author reply 607-8. PubMed ID: 21959730
    [No Abstract]   [Full Text] [Related]  

  • 35. HCV infection should be managed in specialist centres.
    Brown JL
    Gut; 2002 Nov; 51(5):626-7. PubMed ID: 12377797
    [No Abstract]   [Full Text] [Related]  

  • 36. The natural history of surgical infection.
    BURNET FM
    Ann R Coll Surg Engl; 1950 Sep; 7(3):191-203. PubMed ID: 14771773
    [No Abstract]   [Full Text] [Related]  

  • 37. Post liver transplant recurrent and de novo viral infections.
    Jothimani D; Venugopal R; Vij M; Rela M
    Best Pract Res Clin Gastroenterol; 2020; 46-47():101689. PubMed ID: 33158469
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quality of life 10 years after liver transplantation: The impact of graft histology.
    Karam V; Sebagh M; Rifai K; Yilmaz F; Bhangui P; Danet C; Saliba F; Samuel D; Castaing D; Adam R; Feray C
    World J Transplant; 2016 Dec; 6(4):703-711. PubMed ID: 28058221
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interferon Treatment of Hepatitis C Reinfection after Liver Transplantation: A Meta-Analysis.
    Chen Y; Wu G; Zhang H; Xu H; Li H; Chen L; Yang Y; Hu P; Zhang D; Ren H; Hu H
    Gastroenterol Res Pract; 2015; 2015():206302. PubMed ID: 26167174
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A randomized controlled trial of pretransplant antiviral therapy to prevent recurrence of hepatitis C after liver transplantation.
    Everson GT; Terrault NA; Lok AS; Rodrigo del R; Brown RS; Saab S; Shiffman ML; Al-Osaimi AM; Kulik LM; Gillespie BW; Everhart JE;
    Hepatology; 2013 May; 57(5):1752-62. PubMed ID: 22821361
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.